Moreover, as for the NLRP3 inflammasome inhibition, anakinra had no effect on the acute ex vivo effects exerted by visfatin/eNampt, further supporting the existence of both a rapid NLRP3-independent and a long-term NLRP3-dependent mechanism of endothelial dysfunction. The gene discussed is NLRP3; the disease is endothelial dysfunction.